Symbiotiq ApS

CVR 42741809 · Private limited company (ApS) · Active · Low risk

Symbiotiq ApS is a Private limited company (ApS), founded on , based in Odense M. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.1m and a net result of DKK 288k.

Bankruptcy risk for Symbiotiq ApS

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 18% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Gross profit growth10%–30% · bankruptcy rate 4.5%0.51×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42741809
Status
Active
Company type
Private limited company (ApS)
Founded
(5 years)
Address
c/o Hunderupvej 85, Hunderupvej 85
5230 Odense M
Municipality
Odense
Industry
Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse
Share capital
DKK 40k
Auditor
EY Godkendt Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio61.5%
Current ratio257%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 1.4mDKK 1.1mDKK 1.5m
Net profitDKK 288kDKK 586kDKK 898k
EquityDKK 2.1mDKK 1.9mDKK 1.5m
Total assetsDKK 3.4mDKK 2.7mDKK 2.3m
CashDKK 1.3mDKK 69k–
Short-term debtDKK 1.3mDKK 747k–
Tax owedDKK 0DKK 41k–
Avg. employees0––

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · EY Godkendt Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025127
1 Jan 2024 – 31 Dec 202436
1 Jan 2023 – 31 Dec 202337
29 Sep 2021 – 31 Dec 202220

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
Owner (100%)Mads BondeCurrent
FounderMads BondeCurrent

Address history (0 moves)

c/o Hunderupvej 85, Hunderupvej 85, 5230 Odense M

Other companies at the same address

Similar companies in Odense

Questions and answers about Symbiotiq ApS

Has Symbiotiq ApS gone bankrupt?

No, Symbiotiq ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Symbiotiq ApS?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the auditor of Symbiotiq ApS?

Symbiotiq ApS most recently used EY Godkendt Revisionspartnerselskab.

When was Symbiotiq ApS founded?

Symbiotiq ApS was founded on 29 September 2021.

What is the equity of Symbiotiq ApS?

Equity was DKK 2.1m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.